According to Apellis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$2.58 B. In 2023 the company made an earning of -HK$4.11 B an increase over its 2022 earnings that were of -HK$5.08 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.